Clinical Trial Update: Estrogen in the Prevention of Adhesion Reformation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating estrogen to prevent adhesion reformation in Asherman Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asherman Syndrome

Drugs mentioned

• Estrogen (Estrogen)

Snippet

Sponsor: Fu Xing Hospital, Capital Medical University | Conditions: Asherman Syndrome | Phase 4 | Status: UNKNOWN